Changjoon Justin Lee is a neuroscientist specializing in the field of glioscience. He served as the Director of Center for Neuroscience at the Korea Institute of Science and Technology and later founded the WCI Center for Functional Connectomics as part of the World Class Institute Program. In 2015, he established the Center for Glia-Neuron Interaction before becoming co-director of the IBS Center for Cognition and Sociality and head of the Cognitive Glioscience Group in 2018. He has been on the editorial boards of the journals Molecular Brain and Molecular Pain and is a chief editor of Experimental Neurobiology. Born in a rural area of Gimpo City, Lee interacted with the natural world and raised livestock at home which inspired an interest in biology.[1] After completion of middle school, he left South Korea and moved to the US at age 15 and started high school at Rich Central High School, Olympia Fields, Illinois. While under an Illinois State Scholarship[2] and working as a junior research assistant in the lab of Professor Louis Seiden, Lee majored in chemistry and obtained his B.A. from the University of Chicago in 1990. He then moved to New York where he enrolled in the Graduate School of Arts and Sciences of Columbia University where he earned his M.S. and Ph.D. in neurophysiology under the Department of Physiology and Cellular Biophysics. His doctoral thesis adviser was Professor Amy B. MacDermott, whose lab he worked in as a research technician and later as a graduate research assistant upon recipient of his M.S. Before the first year of his joint M.S. and Ph.D. study, he worked as a research assistant in Emily Foster's lab at Michael Reese Hospital. Within Columbia University, he was also a research technician in Professor Martin Low's lab. He then completed a three-year postdoc position in the lab of Professor Traynelis at Emory University in the Department of Pharmacology. His sponsor was Dr. Stephen Traynelis and his research scope was the modulation of NMDA receptors by protease-activated receptors.[3] During the postdoc position, he visited the Korea Institute of Science and Technology (KIST) and was influenced by Shin Hee-sup to join KIST,[1] which he did in 2004 as a senior research scientist. Working at KIST, he became a principle research scientist in 2010 and later a tenured research scientist in 2017. Lee participated in establishing brain science research infrastructure at KIST, first as a founding member of the Center for Neuroscience with director Shin Hee-sup. The Center is now a constituent of KIST's Brain Science Institute. He also helped to establish the Neuroscience Program of the University of Science and Technology (UST). He also participated as a founding faculty of KU-KIST School of Convergence Technology. As a part of World Class Institute program (WCI), he founded the WCI Center for Functional Connectomics in 2009[4] and served as the organizing deputy director of the center.[5][6][7] In November 2018, Lee joined the IBS Center for Cognition and Sociality as a co-director with Shin Hee-sup, who he had previously met and worked with at KIST. Shin led the Social Neuroscience Group until his retirement in 2020[8][9] while Lee leads the Cognitive Glioscience Group which focuses on four research areas: molecular glioscience, glia-neuron interaction, glial plasticity and cognition, and gliopathy. GABA synthesis and release from glia Lee's research group has contributed to the field of gliotransmission by creating several seminal publications on the channel-mediated gamma-Aminobutyric acid (GABA) and glutamate release from astrocytes.[11][12] They later identified the biosynthetic pathway for astrocyte GABA and found monoamine oxidase B to be the key enzyme for GABA production[13] which raised the possibility that astrocytes can directly participate in cognitive processes via astrocytic GABA.[14] His team also found a connection with GABA from reactive astrocytes and impaired memory in mouse models of Alzheimer's disease, leading them to propose astrocytic GABA might be a diagnostic tool, biomarker, and therapeutic target for both neurological diseases Alzheimer's and Parkinson's.[15] The research is notable as it revealed that astrocytes, like neurons, play a significant role in cognitive processes.[16] The findings also resulted in a technology transfer to MegaBioWood[17] which will be prepared for a phase I clinical trial in 2019.[18] In response to his Alzheimer's research related to causes of memory loss, Lee received the Science Day 2017 Presidential Medal of Honor.[19][20] Molecular mechanism of glutamate and d-serine release from glia It is known that glutamate is released from astrocytes but the exact method of their release, i.e., the release mechanism, has been controversial.[21] His team went on to discover two models of glutamate release; a fast mode through TREK-1 in the K2P channel[22] and a slow mode through the Best1 channel in hippocampal astrocytes.[12]